logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Smruthi Vijayaraghavan

university of texas system
H指数:11
被引数:1,398

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

JNJ-87890387, a novel ENPP3 bispecific T-cell redirector (ENPP3xCD3) with tumor selectivity through targeting apical surface antigens
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Vijayaraghavan, Smruthi; Seth, Pankaj; Winkis, Annmarie; Chevalier, Kristen; Marthaler, Alexa; Sproesser, Katrin; Torti, Vince; Shah, Nirav; Lacy, Eilyn; Frisk, Anna-Lena; Deutsch, Heather; Chu, Gerald; Sharp, Michael; Pabalan, Jonathan; Tilegenova, Cholpon; Thorton, Katherine; Lauring, Josh; Mattson, Bethany; Tian, Ken; Kinyamu-Akunda, Jacqueline; Lenox, Laurie; Cheung, Wan Cheung; Moores, Sheri; Laquerre, Sylvie
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications

Amivantamab，一种表皮生长因子受体 (EGFR) 和间充质上皮转化因子 (MET) 双特异性抗体，旨在实现多种作用机制和广泛的临床应用

CLINICAL LUNG CANCER
IF3.3
2023-03-0151
OAAI
Cho, Byoung Chul; Simi, Allison; Sabari, Joshua; Vijayaraghavan, Smruthi; Moores, Sheri; Spira, Alexander
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis

Amivantamab (JNJ-61186372)，一种Fc增强的EGFR/cMet双特异性抗体，通过单核细胞/巨噬细胞吞噬作用诱导受体下调和抗肿瘤活性

MOLECULAR CANCER THERAPEUTICS
IF5.5
2020-10-02132
OAAI
Vijayaraghavan, Smruthi; Lipfert, Lorraine; Chevalier, Kristen; Bushey, Barbara S.; Henley, Benjamin; Lenhart, Ryan; Sendecki, Jocelyn; Beqiri, Marilda; Millar, Hillary J.; Packman, Kathryn; Lorenzi, Matthew, V; Laquerre, Sylvie; Moores, Sheri L.
Combined inhibition of STAT-3 & DNA repair in palbociclib resistant breast cancer
CANCER RESEARCH
IF16.6
2019-07-011
PRE
Kettner, Nicole M.; Vijayaraghavan, Smruthi; Durak, Merih Guray; Bui, Tuyen; Kohansal, Mehrnoosh; Ha, Min Jin; Liu, Bin; Rao, Xiayu; Yang, Jing; Yi, Min; Carey, Jason P.; Chen, Xian; Eckols, T. Kris; Raghavendra, Akshara S.; Ibrahim, Nuhad K.; Karuturi, Meghan; Watowich, Stephanie S.; Sahin, Aysegul A.; Tweardy, David J.; Hunt, Kelly K.; Tripathy, Debu; Keyomarsi, Khandan
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
CLINICAL CANCER RESEARCH
IF10.2
2019-03-1391
OAAI
Kettner, Nicole M.; Vijayaraghavan, Smruthi; Durak, Merih Guray; Bui, Tuyen; Kohansal, Mehrnoosh; Ha, Min Jin; Liu, Bin; Rao, Xiayu; Wang, Jing; Yi, Min; Carey, Jason P. W.; Chen, Xian; Eckols, T. Kris; Raghavendra, Akshara S.; Ibrahim, Nuhad K.; Karuturi, Meghan Sri; Watowich, Stephanie S.; Sahin, Aysegul; Tweardy, David J.; Hunt, Kelly K.; Tripathy, Debu; Keyomarsi, Khandan

研究方向

暂未获取到该数据
K
Khandan Keyomarsi
H 指数:59论文数:603被引数:1.4万
K
Kelly K. Hunt
H 指数:130论文数:1,407被引数:6.0万
S
Sheri L. Moores
H 指数:23论文数:106被引数:3,987
T
Tuyen Bui
H 指数:20论文数:203被引数:1,705
S
Sylvie Laquerre
H 指数:28论文数:209被引数:5,383
A
Akshara Singareeka Raghavendra
H 指数:21论文数:233被引数:1,593
B
Benjamin J. Henley
H 指数:28论文数:187被引数:5,879
C
Cansu Karakaş
H 指数:19论文数:191被引数:1,389
I
Iman Doostan
H 指数:6论文数:47被引数:431
D
Debu Tripathy
H 指数:69论文数:1,158被引数:2.5万